← SynDRA
ZANAMIVIR
SynDRA canonical compound SYN0006781 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NEU2 |
|---|
| Mechanism of action | neuraminidase inhibitor |
|---|
| Indication | influenza A virus infection |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- neuraminidase inhibitor
- Inhibitor
Drug classes
- Neuraminidase Inhibitors
- Neuraminidase Inhibitor
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- relenza
- zanamivir hydrate
- GG-167
- GG167
- GR-121167X
- GR-121167
- Relenza
- 4-Guanidino-Neu5Ac2en
- GANA
- Zanamavir
- MODIFIED SIALIC ACID
- UNII-L6O3XI777I
- GR 121167X
- Zanamivir (Relenza)
- Relenza (TN)
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
- CHEMBL222813
- L6O3XI777I
- ZMR
- CHEBI:50663
- GANA (inhibitor)
- 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
- GNA
- AK163166
- DSSTox_CID_3749
- DSSTox_RID_77184
- DSSTox_GSID_23749
- Zanamivir [USAN:INN:BAN]
- HSDB 7437
- C12H20N4O7
- Zanamivir hydrate
- GR121167X
- Zanamivir (USAN/INN)
- (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- 4-Guanidino-NeueAc2en
- 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- ZNV
- BAC-zanamivir
Look up ZANAMIVIR in the interactive SynDRA portal →